SCHEMBL4007477

SCHEMBL4007477

CCOC(=O)C(F)(F)C(F)(F)C(F)(F)C(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 3/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
THRB P10828 1/20 0.39
HDAC4 P56524 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27186828 0.95 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL8165793 0.93 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL8166839 0.93 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL4885641 0.91 THRB (0.41) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL198069 0.91 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL4392350 0.90 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL6618678 0.89 ALDH1A1 (0.36) ALDH1A1LMNAHSD17B10PKMKDM4E
Ammonia Solution, Strong SCHEMBL27753007 0.89 POLB (0.39) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL2050077 0.89 CA1 (0.43) ALDH1A1LMNAHSD17B10PKMKDM4E
SCHEMBL7721990 0.88 ALDH1A1 (0.34) ALDH1A1LMNAHSD17B10PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110387386-B Cationic photo-curing fluorine-containing oligomer, anti-fingerprint UV (ultraviolet) ink and application of ink in touch screen display 惠州市华泓新材料股份有限公司 2021-10-15 CN claimed
US-20250110101-A1 PER AND POLYFLUOROALKYL SUBSTANCE MEASUREMENT DEXSIL CORPORATION (US) 2025-04-03 US disclosed
EP-4353705-A1 ALCOHOL PRODUCTION METHOD AND COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2024-04-17 EP disclosed
US-20240109826-A1 ALCOHOL PRODUCTION METHOD AND COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2024-04-04 US disclosed
US-20240059860-A1 METHODS AND SYSTEMS FOR DESTRUCTION OF SYNTHETIC PER- AND POLYFLUORO COMPOUNDS CHZ TECHNOLOGIES, LLC 2024-02-22 US disclosed
CN-117295705-A Alcohol production method and composition 大金工业株式会社 2023-12-26 CN disclosed
CN-113045381-B Preparation method of fluorine-containing dihydric alcohol 中蓝晨光化工研究设计院有限公司 2023-06-02 CN disclosed
CN-113045380-B Method for preparing fluorine-containing dihydric alcohol from fluorine-containing cycloolefin 中蓝晨光化工研究设计院有限公司 2023-03-14 CN disclosed
WO-2022239587-A1 ALCOHOL PRODUCTION METHOD AND COMPOSITION ダイキン工業株式会社 2022-11-17 WO disclosed
CN-110387386-B Cationic photo-curing fluorine-containing oligomer, anti-fingerprint UV (ultraviolet) ink and application of ink in touch screen display 惠州市华泓新材料股份有限公司 2021-10-15 CN disclosed
WO-1998042383-A1 CHARGED LIPIDS AND USES FOR THE SAME IMARX PHARMACEUTICAL CORP. (US) 1998-10-01 WO disclosed
US-5674469-A Gas-exchange method of making gas-filled microspheres MOLECULAR BIOSYSTEMS, INC. (US) 1997-10-07 US disclosed
EP-0769969-A1 GAS-FILLED MICROSPHERES WITH FLUORINE-CONTAINING SHELLS MOLECULAR BIOSYSTEMS, INC. (US) 1997-05-02 EP disclosed
US-5606973-A CONTRAST MOLECULAR BIOSYSTEMS, INC. (US) 1997-03-04 US disclosed
WO-1996040280-A2 LIQUID CORE MICRODROPLETS FOR ULTRASOUND IMAGING MOLECULAR BIOSYSTEMS, INC. (US) 1996-12-19 WO disclosed
WO-1996040278-A2 GAS-EXCHANGE METHOD OF MAKING GAS-FILLED MICROSPHERES MOLECULAR BIOSYSTEMS, INC. (US) 1996-12-19 WO disclosed
WO-1996004018-A1 GAS-FILLED MICROSPHERES WITH FLUORINE-CONTAINING SHELLS MOLECULAR BIOSYSTEMS, INC. (US) 1996-02-15 WO disclosed
US-5316686-A Wear resistant fluids THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 1994-05-31 US disclosed
EP-0481431-A2 Pressurized fluid composition and process for making same UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION, Three Cristina Centre (US) 1992-04-22 EP disclosed
US-4302612-A Synthesis of perfluorodialdehydes POLAROID CORPORATION (US) 1981-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109826-A1 ALCOHOL PRODUCTION METHOD AND COMPOSITION ADH1A, ADH1C, ADH5 ALDH1A1 50/4885LMNA 2977/4885HSD17B10 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.